Portal de Periódicos da CAPES

Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases

2021; Oxford University Press; Volume: 27; Issue: 10 Linguagem: Inglês

10.1093/ibd/izab112

1536-4844

Quazim A. Alayo, Aava Khatiwada, Anish Patel, Maria Zulfiqar, Anas Gremida, Alexandra Gutierrez, Richard P. Rood, Matthew A. Ciorba, George P. Christophi, Parakkal Deepak,

Gastrointestinal disorders and treatments

Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel Diseases Quazim A Alayo, MD, MSc, MMSc, Quazim A Alayo, MD, MSc, MMSc Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USADepartment of Internal Medicine, St. Luke's Hospital, Chesterfield, Missouri, USA https://orcid.org/0000-0001-5524-7105 Search for other works by this author on: Oxford Academic PubMed Google Scholar Aava Khatiwada, MD, Aava Khatiwada, MD Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Anish Patel, DO, Anish Patel, DO Division of Gastroenterology, Brooke Army Medical Center, Fort Sam Houston, Texas, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Maria Zulfiqar, MD, Maria Zulfiqar, MD Department of Radiology, Mallinckrodt Institute of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Anas Gremida, MD, Anas Gremida, MD Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Alexandra Gutierrez, MD, MPH, Alexandra Gutierrez, MD, MPH Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Richard P Rood, MD, Richard P Rood, MD Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Matthew A Ciorba, MD, Matthew A Ciorba, MD Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar George Christophi, MD, PhD, George Christophi, MD, PhD Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USADepartment of Medicine, University of Central Florida, Orlando, Florida, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Parakkal Deepak, MBBS MS Parakkal Deepak, MBBS MS Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis School of Medicine, St. Louis, Missouri, USA Address correspondence to: Parakkal Deepak, MBBS, MS, Assistant Professor of Medicine, John T. Milliken Department of Medicine, Division of Gastroenterology, Washington University in St. Louis School of Medicine, 660 S. Euclid Avenue, Campus Box 8124, St. Louis, MO, 63110, USA. E-mail: deepak.parakkal@wustl.edu. https://orcid.org/0000-0002-3436-9784 Search for other works by this author on: Oxford Academic PubMed Google Scholar Inflammatory Bowel Diseases, Volume 27, Issue 10, October 2021, Pages 1698–1702, https://doi.org/10.1093/ibd/izab112 Published: 25 May 2021 Article history Received: 07 March 2021 Editorial decision: 12 April 2021 Published: 25 May 2021